Funding for this research was provided by:
Medibank better health foundation (N/A)
Received: 9 September 2018
Accepted: 6 February 2019
First Online: 13 February 2019
Ethics approval and consent to participate
: Ethics approval was granted by the School of Health Sciences Human Ethics Advisory Group, University of Melbourne (HREC #1648500.1). Written informed consent was obtained from all participants before entering the study.
: Not applicable.
: DJH provides consulting advice to Tissuegene, Merck Serono and TLCBio. CBL receives funding from Taisho Pharmaceutical, Concentric Analgesics, and Inter-K Peptide Therapeutics to conduct pre-clinical research in OA, through contract agreements managed by the University of Sydney.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.